Cardiff Lexington Corporation reported significant financial developments in its latest 10-Q filing for the quarter ending June 30, 2025. The company achieved revenues of $2.79 million for the three months ended June 30, 2025, marking an increase of 89.5% compared to $1.47 million in the same period of the previous year. For the six months, total revenue reached $5.70 million, up 50.4% from $3.79 million in the prior year. The increase in revenue is attributed to a higher settlement realization rate of 43.18% on gross billed charges, compared to 41.80% in the previous year.
Despite the revenue growth, Cardiff Lexington reported a net loss of $1.23 million for the three months ended June 30, 2025, compared to a loss of $131,585 in the same period last year. For the six months, the net loss was $1.68 million, a significant increase from $414,689 in the prior year. The losses were primarily driven by a substantial rise in interest expenses, which totaled $1.84 million for the quarter, compared to $41,347 in the previous year, reflecting increased costs associated with the company's line of credit.
Operationally, Cardiff Lexington has made strategic changes, including the conversion of preferred stock into common stock, which has reduced the number of outstanding preferred shares. The company also reported a decrease in its employee headcount, which is part of its ongoing efforts to streamline operations. As of June 30, 2025, the company had total assets of $26.51 million, up from $23.93 million at the end of 2024, while total liabilities increased to $20.54 million from $16.32 million.
Looking ahead, Cardiff Lexington's management expressed a commitment to pursuing additional acquisitions in the healthcare sector, which they believe will enhance the company's growth potential. However, the company acknowledged the need for further capital to support its operations and acquisition strategy, estimating that between $5 million to $10 million may be required. The company is actively seeking new financing options to address its cash flow needs and to continue its operational plans.
About Cardiff Lexington Corp
About 10-Q Filings
A 10-Q form is an important financial report that public companies in the United States must submit every three months. It gives a clear picture of a company's financial health and recent performance.
Key points about the 10-Q:
- Frequency: Companies file it three times a year, covering the first three quarters. The fourth quarter is covered in a more comprehensive annual report.
-
Content: It includes:
- Financial statements showing the company's current financial position
- Updates from management on the performance and projections of the business
- Information about potential risks the company faces
- Details on how the company is run internally
- Deadline: Must be filed within 40 or 45 days after the quarter ends, depending on the size of the company.
Our Methodology
AssetRoom is committed to providing timely summaries of news from public companies. We use AI to generate these summaries quickly, but they are not reviewed by human experts.
Our method:
- Data Collection: We continuously monitor for new filings (currently limited to US-listed stocks).
- AI-Powered Analysis: Our advanced AI system processes each filing, identifying key information and extracting relevant data.
- Summary Generation: The AI creates a concise, easy-to-understand summary of the filing, highlighting the most important points.
- Publication: The summary is immediately published on our platform, allowing users instant access to the latest information.
- Email users: We distribute round-up emails according to our users preferences, keeping them in the loop with the companies they follow.
Feedback & Corrections
Spot an error or have a suggestion? Contact us.